Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activation.
Anti-citrullinated protein antibodies
HRCT
Neutrophil activation
Pulmonary abnormalities
Rheumatoid arthritis
Rheumatoid factor
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
20 03 2023
20 03 2023
Historique:
received:
09
12
2022
accepted:
22
02
2023
entrez:
21
3
2023
pubmed:
22
3
2023
medline:
23
3
2023
Statut:
epublish
Résumé
The role of the lung for the initiation and progression of rheumatoid arthritis (RA) is still unclear. Up to 10% of RA patients develop interstitial lung disease which remains a clinical challenge. Understanding early disease mechanisms is of great importance. The objective of this study was to determine whether there is an association between peripheral neutrophil phenotypes and presence of pulmonary abnormalities (PA) on chest high-resolution computed tomography (HRCT) in untreated early RA (ueRA). Clinical data and blood were collected, and HRCT performed at diagnosis on 30 consecutive anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor (RF) positive ueRA patients. HRCTs were evaluated for the presence of RA-associated parenchymal, airway and/or pleural abnormalities. Expression of phenotype markers on neutrophils were determined by flow cytometry. Levels of calprotectin, ACPA and RF were measured using immunoassays. The frequency of having any PA was 60%. Airway abnormalities were present in 50%, parenchymal nodules in 43% and interstitial lung abnormalities (ILA) in 10%. Unsupervised multivariate data analysis showed clustering of any PA with neutrophil activation, parameters of inflammation and RF titres. In univariate analysis, the patients with PA displayed significantly increased CD11b and decreased CD62L expression on neutrophils (1.2-fold, p = 0.014; 0.8-fold, p = 0.012) indicating activation and significantly increased RF IgM titre and CRP (5.7-fold, p = 0.0025; 2.3-fold, p = 0.0035) as compared to no PA. Titres of RF, but not ACPA, correlated with expression of the neutrophil activation marker CD11b. A stratified analysis demonstrated that airway involvement was the PA subtype with the strongest association with neutrophil activation. We report a strong association between radiographic airway findings and activation of circulating neutrophils in early RA supporting a role of innate immunity and the lung at disease onset. Our results also indicate different contributions of RF and ACPA in the RA pathogenesis.
Sections du résumé
BACKGROUND
The role of the lung for the initiation and progression of rheumatoid arthritis (RA) is still unclear. Up to 10% of RA patients develop interstitial lung disease which remains a clinical challenge. Understanding early disease mechanisms is of great importance. The objective of this study was to determine whether there is an association between peripheral neutrophil phenotypes and presence of pulmonary abnormalities (PA) on chest high-resolution computed tomography (HRCT) in untreated early RA (ueRA).
METHODS
Clinical data and blood were collected, and HRCT performed at diagnosis on 30 consecutive anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor (RF) positive ueRA patients. HRCTs were evaluated for the presence of RA-associated parenchymal, airway and/or pleural abnormalities. Expression of phenotype markers on neutrophils were determined by flow cytometry. Levels of calprotectin, ACPA and RF were measured using immunoassays.
RESULTS
The frequency of having any PA was 60%. Airway abnormalities were present in 50%, parenchymal nodules in 43% and interstitial lung abnormalities (ILA) in 10%. Unsupervised multivariate data analysis showed clustering of any PA with neutrophil activation, parameters of inflammation and RF titres. In univariate analysis, the patients with PA displayed significantly increased CD11b and decreased CD62L expression on neutrophils (1.2-fold, p = 0.014; 0.8-fold, p = 0.012) indicating activation and significantly increased RF IgM titre and CRP (5.7-fold, p = 0.0025; 2.3-fold, p = 0.0035) as compared to no PA. Titres of RF, but not ACPA, correlated with expression of the neutrophil activation marker CD11b. A stratified analysis demonstrated that airway involvement was the PA subtype with the strongest association with neutrophil activation.
CONCLUSION
We report a strong association between radiographic airway findings and activation of circulating neutrophils in early RA supporting a role of innate immunity and the lung at disease onset. Our results also indicate different contributions of RF and ACPA in the RA pathogenesis.
Identifiants
pubmed: 36941690
doi: 10.1186/s13075-023-03019-5
pii: 10.1186/s13075-023-03019-5
pmc: PMC10026468
doi:
Substances chimiques
Rheumatoid Factor
9009-79-4
Autoantibodies
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44Informations de copyright
© 2023. The Author(s).
Références
Ann Rheum Dis. 2016 Sep;75(9):1722-7
pubmed: 26530319
J Leukoc Biol. 2017 Feb;101(2):599-611
pubmed: 27601627
Curr Opin Rheumatol. 2016 Jan;28(1):76-82
pubmed: 26599384
Radiology. 2004 Jul;232(1):81-91
pubmed: 15166329
Nat Rev Rheumatol. 2019 Oct;15(10):581-596
pubmed: 31455869
Sci Transl Med. 2013 Mar 27;5(178):178ra40
pubmed: 23536012
Nat Rev Rheumatol. 2014 Oct;10(10):593-601
pubmed: 24914698
Arthritis Rheum. 2006 Jan;54(1):38-46
pubmed: 16385494
Best Pract Res Clin Rheumatol. 2017 Feb;31(1):31-41
pubmed: 29221596
Arthritis Rheumatol. 2020 Jan;72(1):47-56
pubmed: 31353807
Gut. 2018 Jun;67(6):1052-1063
pubmed: 28468761
Arch Intern Med. 2008 Jan 28;168(2):159-66
pubmed: 18227362
Arthritis Rheumatol. 2014 Jan;66(1):31-9
pubmed: 24449573
Arthritis Rheum. 2013 Oct;65(10):2545-54
pubmed: 23817979
Arthritis Rheumatol. 2022 Jan;74(1):38-48
pubmed: 34369110
Clin Chest Med. 2019 Sep;40(3):545-560
pubmed: 31376890
Nat Rev Dis Primers. 2018 Feb 08;4:18001
pubmed: 29417936
J Inflamm (Lond). 2013 Jul 31;10(1):27
pubmed: 23902799
Lupus Sci Med. 2021 Mar;8(1):
pubmed: 33685997
Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):528-35
pubmed: 9279235
RMD Open. 2020 Sep;6(2):
pubmed: 32917833
Autoimmun Rev. 2021 Feb;20(2):102735
pubmed: 33346115
JCI Insight. 2020 Jul 9;5(13):
pubmed: 32484790